Log in

Immunodiagnostic Systems Stock Price, Forecast & Analysis (LON:IDH)

GBX 284
-3.00 (-1.05 %)
(As of 11/13/2019 08:02 AM ET)
Today's Range
Now: GBX 284
50-Day Range
MA: GBX 259.04
52-Week Range
Now: GBX 284
Volume1,344 shs
Average Volume1,203 shs
Market Capitalization£81.75 million
P/E Ratio105.19
Dividend Yield0.25%
Immunodiagnostic Systems Holdings PLC develops, manufactures, and sells in-vitro diagnostic tests to the clinical laboratory market in the United Kingdom, the United States, Germany, France, and internationally. It develops, manufactures, and markets immunoassays and automated immunoanalyser technologies to provide diagnostic outcomes for patients. It offers IDS-iSYS multi-discipline automated systems, which is based on chemiluminescence and absorbency technology is used for immunoassay testing. Read More…

Industry, Sector and Symbol

Industry Medical Appliances & Equipment



Sales & Book Value

Annual Sales£38.51 million
Cash FlowGBX 94.11 per share
Book ValueGBX 191.80 per share



Market Cap£81.75 million
Next Earnings DateN/A
OptionableNot Optionable

Receive IDH News and Ratings via Email

Sign-up to receive the latest news and ratings for IDH and its competitors with MarketBeat's FREE daily newsletter.

Immunodiagnostic Systems (LON:IDH) Frequently Asked Questions

What is Immunodiagnostic Systems' stock symbol?

Immunodiagnostic Systems trades on the London Stock Exchange (LON) under the ticker symbol "IDH."

How often does Immunodiagnostic Systems pay dividends? What is the dividend yield for Immunodiagnostic Systems?

Immunodiagnostic Systems declared a dividend on Wednesday, June 19th. Stockholders of record on Thursday, July 18th will be given a dividend of GBX 0.70 per share on Friday, August 16th. This represents a dividend yield of 0.37%. The ex-dividend date of this dividend is Thursday, July 18th. The official announcement can be viewed at this link. View Immunodiagnostic Systems' Dividend History.

How were Immunodiagnostic Systems' earnings last quarter?

Immunodiagnostic Systems Holdings PLC (LON:IDH) issued its quarterly earnings results on Wednesday, June, 20th. The company reported $5.70 earnings per share for the quarter, beating the consensus estimate of $2.60 by $3.10. View Immunodiagnostic Systems' Earnings History.

Has Immunodiagnostic Systems been receiving favorable news coverage?

Media headlines about IDH stock have trended very negative on Wednesday, InfoTrie reports. The research firm scores the sentiment of press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Immunodiagnostic Systems earned a news sentiment score of -3.2 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the next few days. View News Stories for Immunodiagnostic Systems.

Who are some of Immunodiagnostic Systems' key competitors?

What other stocks do shareholders of Immunodiagnostic Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Immunodiagnostic Systems investors own include Dechra Pharmaceuticals (DPH), Redrow (RDW), iShares Nasdaq Biotechnology ETF (IBB), WisdomTree U.S. Multifactor Fund (USMF), Tp Icap (TCAP), Telford Homes (TEF), Netflix (NFLX), SYSCO (SYY), Arcontech Group (ARC) and Alliance Pharma (APH).

Who are Immunodiagnostic Systems' key executives?

Immunodiagnostic Systems' management team includes the folowing people:
  • Mr. Jaap Stuut, CEO & Director (Age 49)
  • Mr. Paul J. Martin, Group Fin. Director, Company Sec. & Director
  • Nicola Mitton, Group HR Director
  • Mr. Ed Coombes, Head Of Bus. Devel. - Instrumentation (Age 48)
  • Dr. Rudolf Schemer, CEO of GeschTMaftsfuhrer at IDS GmbH Frankfurt & Country Mang. of Germany Region (Age 58)

How do I buy shares of Immunodiagnostic Systems?

Shares of IDH and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Immunodiagnostic Systems' stock price today?

One share of IDH stock can currently be purchased for approximately GBX 284.

How big of a company is Immunodiagnostic Systems?

Immunodiagnostic Systems has a market capitalization of £81.75 million and generates £38.51 million in revenue each year. Immunodiagnostic Systems employs 283 workers across the globe.View Additional Information About Immunodiagnostic Systems.

What is Immunodiagnostic Systems' official website?

The official website for Immunodiagnostic Systems is http://www.idsplc.com/.

How can I contact Immunodiagnostic Systems?

Immunodiagnostic Systems' mailing address is 10 Didcot Way, BOLDON, NE35 9PD, United Kingdom. The company can be reached via phone at +44-191-5190660.

MarketBeat Community Rating for Immunodiagnostic Systems (LON IDH)

Community Ranking:  1.6 out of 5 (star)
Outperform Votes:  91 (Vote Outperform)
Underperform Votes:  189 (Vote Underperform)
Total Votes:  280
MarketBeat's community ratings are surveys of what our community members think about Immunodiagnostic Systems and other stocks. Vote "Outperform" if you believe IDH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IDH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/13/2019 by MarketBeat.com Staff

Featured Article: Bollinger Bands

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel